RCA
CYAD

Ranch Capital Advisors’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Ranch Capital Advisors’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed – – 641
2021
Q3 		$0 Hold
4
– – ﹤0.01% 683
2021
Q2 		$0 Hold
4
– – ﹤0.01% 915
2021
Q1 		$0 Hold
4
– – ﹤0.01% 923
2020
Q4 		$0 Hold
4
– – ﹤0.01% 926
2020
Q3 		$0 Hold
4
– – ﹤0.01% 955
2020
Q2 		$0 Buy
+4
New +$39 ﹤0.01% 1013

Other funds holding CYAD

FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ranch Capital Advisors's CYAD Position: Q4 2021 in Review

Ranch Capital Advisors sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q4 2021, closing a stake of 4 shares.

Ranch Capital Advisors first reported a position in CYAD in Q2 2020 and held it in 6 quarters. The position peaked at $0 in Q3 2021. 10 funds tracked by Wall St. Rank hold CYAD as of Q4 2021.

  • Ranch Capital Advisors reported no remaining Celyad Oncology SA American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Ranch Capital Advisors sold 4 Celyad Oncology SA American Depositary Shares shares in Q4 2021.
  • Ranch Capital Advisors first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2020 and held it in 6 quarters.
  • Ranch Capital Advisors's Celyad Oncology SA American Depositary Shares position peaked at $0 in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q4 2021.

Based on Ranch Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.